Afya/$AFYA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Afya

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

Ticker

$AFYA
Primary listing

Employees

-

Headquarters

Nova Lima, Brazil

Afya Metrics

BasicAdvanced
$1.4B
10.81
$1.39
0.54
$0.23
1.54%

What the Analysts think about Afya

Analyst ratings (Buy, Hold, Sell) for Afya stock.

Bulls say / Bears say

Q2 2025 revenue increased 13.5% YoY to R$919.4 million (8.5% excluding acquisitions), demonstrating strong demand across Afya’s education and solutions divisions.
Adjusted EBITDA rose 16.6% YoY to R$400.8 million, with a 110 basis point margin gain up to 43.6%, showing solid operational leverage and cost control.
The acquisition of FUNIC in May 2025 added 60 approved medical seats, bringing Afya’s total to 3,653 and strengthening its leading undergraduate position in Brazil.
Residency Journey enrollments in the Continuing Education segment fell 29.4% YoY to 9,224 students in H1 2025, reflecting decreased demand for Afya’s medical residency preparatory programs.
Monthly Active Users in the Medical Practice Solutions segment decreased 9.1% YoY to 230,468 in H1 2025, pointing to possible challenges with user engagement and retention.
Adjusted Net Income for Q2 2025 slipped 0.4% YoY to R$209.4 million, indicating some pressure on core profitability despite higher reported net income.
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2025.

Afya Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Afya Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AFYA

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs